Variant G57E of Mannose Binding Lectin associated with protection against tuberculosis caused by mycobacterium africanum but not by M. tuberculosis

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Thye, Thorsten ^a,b   Niemann, Stefan ^c   Walter, Kerstin ^c   Homolka, Susanne ^c   Intemann, Christopher D ^a,b   Chinbuah, Margaret Amanua ^d   Enimil, Anthony ^e   Gyapong, John ^d   Osei, Ivy ^d   Owusu Dabo, Ellis ^e,f   Rüsch Gerdes, Sabine ^c   Horstmann, Rolf D ^a   Ehlers, Stefan ^c,g   Meyer, Christian G ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c RESEARCH CENTER BORSTEL   (Germany)

^d Health Research Unit Ghana Health Service   (Ghana)

^e KUMASI CENTRE FOR COLLABORATIVE RESEARCH IN TROPICAL MEDICINE   (Ghana)

^f KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^g UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MANNOSE BINDING LECTIN;

ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; IN VITRO STUDY; INFECTION PREVENTION; INFECTION RESISTANCE; LUNG TUBERCULOSIS; MACROPHAGE; MYCOBACTERIUM AFRICANUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; TUBERCULOSIS CONTROL; CASE CONTROL STUDY; CLASSIFICATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS; METABOLISM; MICROBIOLOGY; PATHOGENICITY; SINGLE NUCLEOTIDE POLYMORPHISM; SPECIES DIFFERENCE; VIROLOGY;

MYCOBACTERIUM AFRICANUM; MYCOBACTERIUM TUBERCULOSIS;

CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HIV; HUMANS; MANNOSE-BINDING LECTIN; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SPECIES SPECIFICITY; TUBERCULOSIS, PULMONARY;

EID: 79958741438     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020908     Document Type: Article

References (52)

1. Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ, et al. (2000) Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 68: 688-693.
2. Madsen HO, Satz ML, Hogh B, Svejgaard A, Garred P, (1998) Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol 161: 3169-3175.
3. Garred P, Larsen F, Seyfarth J, Fujita R, Madsen HO, (2006) Mannose-binding lectin and its genetic variants. Genes Immun 7: 85-94.
4. Eisen DP, Minchinton RM, (2003) Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 37: 1496-1505.
5. Bernig T, Taylor JG, Foster CB, Staats B, Yeager M, et al. (2004) Sequence analysis of the mannose-binding lectin (MBL2) gene reveals a high degree of heterozygosity with evidence of selection. Genes Immun 5: 461-476.
6. Tsutsumi A, Takahashi R, Sumida T, (2005) Mannose binding lectin: genetics and autoimmune disease. Autoimmun Rev 4: 364-372.
7. Bellamy R, Ruwende C, McAdam KP, Thursz M, Sumiya M, et al. (1998) Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in Africans. Qjm 91: 13-18.
8. Hoal-Van Helden EG, Epstein J, Victor TC, Hon D, Lewis LA, et al. (1999) Mannose-binding protein B allele confers protection against tuberculous meningitis. Pediatr Res 45: 459-64.
9. El Sahly HM, Reich RA, Dou SJ, Musser JM, Graviss EA, (2004) The effect of mannose binding lectin gene polymorphisms on susceptibility to tuberculosis in different ethnic groups. Scand J Infect Dis 36: 106-108.
10. Soborg C, Madsen HO, Andersen AB, Lillebaek T, Kok-Jensen A, et al. (2003) Mannose-binding lectin polymorphisms in clinical tuberculosis. J Infect Dis 188: 777-782.
11. Selvaraj P, Narayanan PR, Reetha AM, (1999) Association of functional mutant homozygotes of the mannose binding protein gene with susceptibility to pulmonary tuberculosis in India. Tuber Lung Dis 79: 221-227.
12. Fitness J, Floyd S, Warndorff DK, Sichali L, Malema S, (2004) Large-scale candidate gene study of tuberculosis susceptibility in the Karonga district of northern Malawi. Am J Trop Med Hyg 71: 341-349.
13. Liu W, Zhang F, Xin ZT, Zhao QM, Wu XM, (2006) Sequence variations in the MBL gene and their relationship to pulmonary tuberculosis in the Chinese Han population. Int J Tuberc Lung Dis 10: 1098-1103.
14. Lopez B, Aguilar D, Orozco H, Burger M, Espitia C, et al. (2003) A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol 133: 30-37.
15. Caws M, Thwaites G, Dunstan S, Hawn TR, Lan NT, et al. (2008) The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog 4: e1000034.
16. Herb F, Thye T, Niemann S, Browne EN, Chinbuah MA, et al. (2008) ALOX5 variants associated with susceptibility to human pulmonary tuberculosis. Hum Mol Genet 17: 1052-1060.
17. Intemann CD, Thye T, Niemann S, Browne EN, Amanua Chinbuah M, et al. (2009) Autophagy gene variant IRGM-261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M africanum strains. PLoS Pathog 5: e1000577.
18. Dommett RM, Klein N, Turner MW, (2006) Mannose-binding lectin in innate immunity: past, present and future. Tissue Antigens 68: 193-209.
19. Leemans JC, Juffermans NP, Florquin S, van Rooijen N, Vervoordeldonk MJ, et al. (2001) Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice. J Immunol 166: 4604-4611.
20. Schlesinger LS, (1993) Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J Immunol 150: 2920-2930.
21. Ehlers MR, Daffe M, (1998) Interactions between Mycobacterium tuberculosis and host cells: are mycobacterial sugars the key? Trends Microbiol 6: 328-335.
22. Hershberg R, Lipatov M, Small PM, Sheffer H, Niemann S, et al. (2008) High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS Biol 6: e311.
23. Gagneux S, Small PM, (2007) Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis 7: 328-337.
24. Kuhlman M, Joiner K, Ezekowitz RA, (1989) The human mannose-binding protein functions as an opsonin. J Exp Med 169: 1733-1745.
25. Polotsky VY, Belisle JT, Mikusova K, Ezekowitz RA, Joiner KA, (1997) Interaction of human mannose-binding protein with Mycobacterium avium. J Infect Dis 175: 1159-1168.
26. Townsend R, Read RC, Turner MW, Klein NJ, Jack DL, (2001) Differential recognition of obligate anaerobic bacteria by human mannose-binding lectin. Clin Exp Immunol 124: 223-228.
27. van Emmerik LC, Kuijper EJ, Fijen CA, Dankert J, Thiel S, (1994) Binding of mannan-binding protein to various bacterial pathogens of meningitis. Clin Exp Immunol 97: 411-416.
28. Jack A, et al. (1998) Activation of complement by mannose-binding lectin on isogenic mutants of Neisseria meningitidis serogroup B. J Immunol 160: 1346-1353.
29. Casanova JL, Abel L, (2004) Human Mannose-binding Lectin in Immunity: Friend, Foe, or Both? J Exp Med 199: 1295-1299.
30. Verdu P, Barreiro LB, Patin E, Gessain A, Cassar O, et al. (2006) Evolutionary insights into the high worldwide prevalence of MBL2 deficiency alleles. Hum Mol Genet 15: 2650-2658.
31. Hill AV, (2006) Aspects of genetic susceptibility to human infectious diseases. Annu Rev Genet 40: 469-486.
32. Dahl M, Tybjaerg-Hansen A, Schnohr P, Nordestgaard BG, (2004) A population-based study of morbidity and mortality in mannose-binding lectin deficiency. J Exp Med 199: 1391-1399.
33. Tacx AN, Groeneveld AB, Hart MH, Aarden LA, Hack CE, (2003) Mannan binding lectin in febrile adults: no correlation with microbial infection and complement activation. J Clin Pathol 56: 956-959.
34. Garred P, Nielsen MA, Kurtzhals JA, Malhotra R, Madsen HO, et al. (2003) Mannose-binding lectin is a disease modifier in clinical malaria and may function as opsonin for Plasmodium falciparum-infected erythrocytes. Infect Immun 71: 5245-5253.
35. Garred P, Harboe M, Oettinger T, Koch C, Svejgaard A, (1994) Dual role of mannan-binding protein in infections: another case of heterosis? Eur J Immunogenet 21: 125-131.
36. Lipscombe RJ, Beatty DW, Ganczakowski M, Goddard EA, Jenkins T, et al. (1996) Mutations in the human mannose-binding protein gene: frequencies in several population groups. Eur J Hum Genet 4: 13-19.
37. Luty AJ, Kun JF, Kremsner PG, (1998) Mannose-binding lectin plasma levels and gene polymorphisms in Plasmodium falciparum malaria. J Infect Dis 178: 1221-1224.
38. Wirth T, Hildebrand F, Allix-Beguec C, Wolbeling F, Kubica T, et al. (2008) Origin, spread and demography of the Mycobacterium tuberculosis complex. PLoS Pathog 4: e1000160.
39. de Jong BC, Antonio M, Gagneux S, (2010) Mycobacterium africanum-review of an important cause of human tuberculosis in West Africa. PLoS Negl Trop Dis 4: e744.
40. Hartl DL, (2004) The origin of malaria: mixed messages from genetic diversity. Nat Rev Microbiol 2: 15-22.
41. Thye T, Browne EN, Chinbuah MA, Gyapong J, Osei I, et al. (2006) No associations of human pulmonary tuberculosis with Sp110 variants. J Med Genet 43: e32.
42. Thye T, Nejentsev S, Intemann CD, Browne EN, Chinbuah MA, et al. (2009) MCP-1 promoter variant -362C associated with protection from pulmonary tuberculosis in Ghana, West Africa. Hum Mol Genet 18: 381-388.
43. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, et al. (1997) Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 35: 907-914.
44. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, et al. (1993) Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 31: 406-409.
45. Niemann S, Kubica T, Bange FC, Adjei O, Browne EN, et al. (2004) The species Mycobacterium africanum in the light of new molecular markers. J Clin Microbiol 42: 3958-3962.
46. Owusu-Dabo E, Adjei O, Meyer CG, Horstmann RD, Enimil A, et al. (2006) Mycobacterium tuberculosis drug resistance. Ghana Emerg Infect Dis 12: 1171-1172.
47. Bernig T, Breunis W, Brouwer N, Hutchinson A, Welch R, et al. (2005) An analysis of genetic variation across the MBL2 locus in Dutch Caucasians indicates that 3′ haplotypes could modify circulating levels of mannose-binding lectin. Hum Genet 118: 404-415.
48. Lozano F, Suarez B, Munoz A, Jensenius JC, Mensa J, et al. (2005) Novel MASP2 variants detected among North African and Sub-Saharan individuals. Tissue Antigens 66: 131-135.
49. Asgharzadeh M, Hanifi G, Roudsary AA, Habibi G, Kafil HS, et al. (2008) Mannose Binding Lectin Gene Polymorphism in Azarian Population of Iran Research. Journal of Biological Sciences 3: 13-17.
50. Lee SG, Yum JS, Moon HM, Kim HJ, Yang YJ, et al. (2005) Analysis of mannose-binding lectin 2 (MBL2) genotype and the serum protein levels in the Korean population. Mol Immunol 42: 969-977.
51. Matsushita M, Hijikata M, Ohta Y, Mishiro S, (1998) Association of mannose-binding lectin gene haplotype LXPA and LYPB with interferon-resistant hepatitis C virus infection in Japanese patients. J Hepatol 29: 695-700.
52. Turner MW, Dinan L, Heatley S, Jack DL, Boettcher B, et al. (2000) Restricted polymorphism of the mannose-binding lectin gene of indigenous Australians. Hum Mol Genet 9: 1481-1486.